Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Ministry of Science Partners with Peptris for AI-Based Drug Discovery Project

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Technology

Ministry of Science Partners with Peptris for AI-Based Drug Discovery Project

Analysed 12 Oct 2026·2 sources analysed·New Delhi, India·Technology
Ministry of Science Partners with Peptris for AI-Based Drug Discovery ProjectPreviousNext

The Ministry of Science's Technology Development Board has signed a memorandum of understanding with Bengaluru-based Peptris Technologies to support the AI-driven drug discovery project 'VIGOR.' With a total budget of Rs 172 crore, including Rs 86 crore in financial aid via optionally convertible debt, the initiative aims to advance four experimental drugs targeting conditions like neuromuscular disorders and diabetes from preclinical stages to clinical trial readiness. Officials highlighted AI's potential to transform pharmaceutical research while emphasizing the need for sustained investment and rigorous validation.

Sentiment
75%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 43/100.

Outlets measured: economictimes, hindustantimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 12 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (75/100)

Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

hindustantimes broke this story on 12 Oct, 11:02 am. Other outlets followed.

12 Oct, 11:02 am2 sources · 3 min12 Oct, 11:05 am
AI analysis by the TBN Bias Engine · beat methodology byAshwin Alsi· Technology Editor· editorial standards byOjas Kale
← Previous
Kawasaki Unveils Z300 Streetfighter Motorcycle in India with Bookings Opening Soon
Next →
Former Microsoft Engineer Leaves Job to Develop AI Financial Coaching Startup
1
hindustantimes12 Oct, 11:02 am
Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development
  • 2
    economictimes12 Oct, 11:05 am
    AI-based drug discovery: Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Ministry of ScienceMinistry of Science's Technology Development BoardTechnology Development Board
    Corporate
    Peptris Technologies Private Limited

    Story context

    Category
    Tech
    Location
    New Delhi, India
    Sources analysed
    2
    Last analysed
    12 Oct 2026
    Key entities
    Drug discoveryArtificial intelligenceCroreIndian rupeePreclinical developmentBarycentric Dynamical TimeExperimental drugDrug developmentClinical trialPharmacyMedicationBiotechnology